The Source Blog
Recent Action in Pharmaceuticals
HB2107 – Virginia
Introduced: 2025 Status: In Process
This bill amends Virginia law to expand patient choice and restrict certain practices by health insurers, health maintenance organizations (HMOs), and pharmacy benefits managers (PBMs). Specifically, the bill prohibits these entities from imposing policies or […]
HB2773 – Virginia
Introduced: 2025 Status: In Process
This bill addresses several key provisions related to health insurance, pharmacy benefits managers (PBMs), and prescription drug cost-sharing. The legislation introduces new requirements for carriers and PBMs in Virginia, focusing on transparency, cost reduction, and […]
HB2048 – Oklahoma
Introduced: 2025 Status: In Process
This bill establishes the 340B Nondiscrimination Act, which aims to protect entities participating in the federal 340B drug discount program from discriminatory practices by health insurers, pharmacy benefits managers (PBMs), manufacturers, and distributors. The bill […]
HB2817 – Oklahoma
Introduced: 2025 Status: In Process
This bill creates the Oklahoma Rebate Pass-Through and Pharmacy Benefits Manager (PBM) Meaningful Transparency Act of 2025, which aims to increase transparency and regulate the practices of pharmacy benefits managers and health insurers in Oklahoma. […]
SB773 – Oklahoma
Introduced: 2025 Status: In Process
This bill modifies Oklahoma’s existing laws regarding Pharmacy Benefit Managers (PBMs), expanding regulatory oversight and imposing stricter requirements on their operations. The bill updates definitions of key terms like “pharmacy benefits manager” and “pharmacy benefits […]
SB789 – Oklahoma
Introduced: 2025 Status: In Process
This bill makes several significant changes to regulations governing pharmacy benefit managers (PBMs) in Oklahoma, focusing on audit procedures, record-keeping, and reimbursement practices. The legislation permits pharmacies to use drug purchase records without date or […]
SB1025 – Oklahoma
Introduced: 2025 Status: In Process
This bill introduces the Oklahoma Rebate Pass-Through and Pharmacy Benefits Manager Meaningful Transparency Act of 2025, which aims to regulate pharmacy benefits managers (PBMs) and health insurers in Oklahoma by expanding transparency and consumer protections […]
Next | See all Legislation Records
Introduced: 2025 Status: In Process
This bill amends Virginia law to expand patient choice and restrict certain practices by health insurers, health maintenance organizations (HMOs), and pharmacy benefits managers (PBMs). Specifically, the bill prohibits these entities from imposing policies or […]
HB2773 – Virginia
Introduced: 2025 Status: In Process
This bill addresses several key provisions related to health insurance, pharmacy benefits managers (PBMs), and prescription drug cost-sharing. The legislation introduces new requirements for carriers and PBMs in Virginia, focusing on transparency, cost reduction, and […]
HB2048 – Oklahoma
Introduced: 2025 Status: In Process
This bill establishes the 340B Nondiscrimination Act, which aims to protect entities participating in the federal 340B drug discount program from discriminatory practices by health insurers, pharmacy benefits managers (PBMs), manufacturers, and distributors. The bill […]
HB2817 – Oklahoma
Introduced: 2025 Status: In Process
This bill creates the Oklahoma Rebate Pass-Through and Pharmacy Benefits Manager (PBM) Meaningful Transparency Act of 2025, which aims to increase transparency and regulate the practices of pharmacy benefits managers and health insurers in Oklahoma. […]
SB773 – Oklahoma
Introduced: 2025 Status: In Process
This bill modifies Oklahoma’s existing laws regarding Pharmacy Benefit Managers (PBMs), expanding regulatory oversight and imposing stricter requirements on their operations. The bill updates definitions of key terms like “pharmacy benefits manager” and “pharmacy benefits […]
SB789 – Oklahoma
Introduced: 2025 Status: In Process
This bill makes several significant changes to regulations governing pharmacy benefit managers (PBMs) in Oklahoma, focusing on audit procedures, record-keeping, and reimbursement practices. The legislation permits pharmacies to use drug purchase records without date or […]
SB1025 – Oklahoma
Introduced: 2025 Status: In Process
This bill introduces the Oklahoma Rebate Pass-Through and Pharmacy Benefits Manager Meaningful Transparency Act of 2025, which aims to regulate pharmacy benefits managers (PBMs) and health insurers in Oklahoma by expanding transparency and consumer protections […]
Next | See all Legislation Records
Merck & Co., Inc. v. Becerra, et al. – Federal
District Court: District of Columbia Status: Pending
A complaint filed by Merck, a multinational pharmaceutical company, alleges that the drug price negotiation process detailed in the Inflation Reduction Act (IRA) violates the […]
FTC v. Amgen Inc. & Horizon Therapeutics Plc. – Federal
District Court: Northern District of Illinois, Eastern Division Status: Pending
The FTC filed a lawsuit requesting a temporary restraining order and preliminary injunction to block Amgen Inc. from acquiring Horizon Therapeutics. Amgen agreed to purchase […]
PhRMA v. Stolfi – Oregon
District Court: District Court of Oregon Status: Decided
PhRMA is challenging Oregon’s drug price transparency laws HB 4005, 2018 (Disclosure Law) and HB 2658, 2019 (Advance Notification Law) alleging that the laws are […]
Pharmaceutical Care Management Association (PCMA) v. Mulready – Oklahoma
District Court: District Court of Western District of Oklahoma Status: Decided
The 2019 Oklahoma law, Patient’s Right to Pharmacy Choice Act, targets PBM conflict of interest by prohibiting higher reimbursement rates for PBM-owned pharmacies and bans […]
State of Ohio v. OptumRx – Ohio
District Court: Ohio Court of Common Pleas (Franklin County) Status: Pending
On March 15, 2019, Ohio’s attorney general Dave Yost sued OptumRx in Ohio state court, claiming that between 2015 and 2018, the PBM failed to pass […]
Pharm. Care Mgmt. Ass’n v. Gerhart – Iowa
District Court: Southern District of Iowa Status: Decided
Trade association representing pharmacy benefits managers (PBM) brought action against State of Iowa, seeking declaration that statute that regulated how PBMs established generic drug pricing […]
Pharm. Care Mgmt. Ass’n v. Tufte – North Dakota
District Court: District of North Dakota Status: Pending
Trade association representing pharmacy benefit managers (PBMs) brought action against North Dakota state officials in their official capacities, alleging that Employee Retirement Income Security Act […]
Next | See all Litigation Records
District Court: District of Columbia Status: Pending
A complaint filed by Merck, a multinational pharmaceutical company, alleges that the drug price negotiation process detailed in the Inflation Reduction Act (IRA) violates the […]
FTC v. Amgen Inc. & Horizon Therapeutics Plc. – Federal
District Court: Northern District of Illinois, Eastern Division Status: Pending
The FTC filed a lawsuit requesting a temporary restraining order and preliminary injunction to block Amgen Inc. from acquiring Horizon Therapeutics. Amgen agreed to purchase […]
PhRMA v. Stolfi – Oregon
District Court: District Court of Oregon Status: Decided
PhRMA is challenging Oregon’s drug price transparency laws HB 4005, 2018 (Disclosure Law) and HB 2658, 2019 (Advance Notification Law) alleging that the laws are […]
Pharmaceutical Care Management Association (PCMA) v. Mulready – Oklahoma
District Court: District Court of Western District of Oklahoma Status: Decided
The 2019 Oklahoma law, Patient’s Right to Pharmacy Choice Act, targets PBM conflict of interest by prohibiting higher reimbursement rates for PBM-owned pharmacies and bans […]
State of Ohio v. OptumRx – Ohio
District Court: Ohio Court of Common Pleas (Franklin County) Status: Pending
On March 15, 2019, Ohio’s attorney general Dave Yost sued OptumRx in Ohio state court, claiming that between 2015 and 2018, the PBM failed to pass […]
Pharm. Care Mgmt. Ass’n v. Gerhart – Iowa
District Court: Southern District of Iowa Status: Decided
Trade association representing pharmacy benefits managers (PBM) brought action against State of Iowa, seeking declaration that statute that regulated how PBMs established generic drug pricing […]
Pharm. Care Mgmt. Ass’n v. Tufte – North Dakota
District Court: District of North Dakota Status: Pending
Trade association representing pharmacy benefit managers (PBMs) brought action against North Dakota state officials in their official capacities, alleging that Employee Retirement Income Security Act […]
Next | See all Litigation Records
News & Opinions
Articles & Reports
Health Affairs Forefront
October 10, 2024
Health Affairs August 29, 2024
Health Affairs August 13, 2024
Health Affairs August 5, 2024
Health Affairs August 29, 2024
Health Affairs August 13, 2024
Health Affairs August 5, 2024
Trends in Pharmaceuticals
2019 Pharmaceutical Legislation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2019 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Price Transparency
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Rate Setting
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Price Gouging
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Drug Importation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Pharmacy Gag Clause Regulation
Gag clause regulation includes laws that allow pharmacists to disclose costs to insured patients and those that prohibit pharmacists from collecting more in cost-sharing from the insured patient than the cash price. See The Source’s Spotlight on 2018 State Drug Legislation Part 3 and 2018 legislation chart for more information.
-
Key:
- Enacted
- Considered
- No Legislative Session
PBM Regulation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Pharma Other
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session